Human TET2 -Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny
Authors:
- Hector Huerga EncaboHEHector Huerga Encabo
- Giuseppe D’AGostinoGDGiuseppe D’AGostino
- Katherine SturgessKSKatherine Sturgess
- Alice E. LordALAlice E. Lord
- Eric D. JongEJEric D. Jong
- Alessandra FerrelliAFAlessandra Ferrelli
- Aneesh SharmaASAneesh Sharma
- Syed A. MianSMSyed A. Mian
- Khadidja HabelKHKhadidja Habel
- Miriam Llorian-SopenaMLMiriam Llorian-Sopena
- Amirtha Priya RameshARAmirtha Priya Ramesh
- Fatihah Mohamad NorFNFatihah Mohamad Nor
Open Access
- 3 December 2025
- journal article
- Published by American Association for Cancer Research (AACR) in Blood Cancer Discovery
- Vol. 7 (2) , 287-305
Abstract
Clonal hematopoiesis (CH) increases with age and is associated with severe outcome in the course of infections or tumor development. Understanding the environmental conditions that favor mutant clones and the CH immune system response to such environments is key to designing therapeutic strategies to stall the expansion of mutant clones and the development of CH-associated pathologies. Using human cells, we unravel a cell-specific and opposite impact of TET2 mutations on hematopoietic stem and progenitor cells (HSPC) compared with their myeloid progeny. Multi-omic analyses reveal that TET2-mutant HSPCs exhibit intrinsic epigenetic silencing of AP-1 transcription factors and a blunted transcriptional adaptation to systemic inflammation. Conversely, monocyte–macrophage trajectory derived from TET2Mut hematopoietic stem cells (HSC) contributes to exacerbated inflammation. Together, these findings reconcile how TET2-mutant CH can simultaneously promote increased stemness within the HSPC compartment and heightened inflammation through its myeloid progeny, providing mechanistic insight into how TET2-CH expands under inflammatory stress. Significance: This study reveals that stress conditions inducing emergency myelopoiesis expand human TET2-mutant clones. TET2 mutation triggers an epigenetic silencing of AP-1 factors contributing to the dampening of the inflammatory responsiveness in TET2mut HSPCs while simultaneously promoting hyperinflammatory TET2mut monocyte–macrophage activation and differentiation, reinforcing inflammation.Keywords
All Related Versions
Funding Information
- Cancer Research UK (CC2027)
- European Hematology Association (Kick-off grant)
- Kay Kendall Leukaemia Fund (KKL1397)
- Medical Research Council (CC2027)
- Wellcome Trust (CC2027)
This publication has 71 references indexed in Scilit:
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34+ cellsExperimental Hematology, 2012
- Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in miceProceedings of the National Academy of Sciences, 2011
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011
- Irradiation induces bone injury by damaging bone marrow microenvironment for stem cellsProceedings of the National Academy of Sciences, 2011
- Lipopolysaccharide-induced c-Jun NH2-terminal Kinase Activation in Human NeutrophilsJournal of Biological Chemistry, 2004
- JNK‐interacting protein 3 associates with Toll‐like receptor 4 and is involved in LPS‐mediated JNK activationThe EMBO Journal, 2003
- Activation of JNK Signaling Pathway by Erythropoietin, Thrombopoietin, and Interleukin-3Blood, 1997
- Regulation of c-jun expression and AP-1 enhancer activity by granulocyte-macrophage colony-stimulating factor.Journal of Biological Chemistry, 1991